SCHEMBL7076294

SCHEMBL7076294

Nc1ccc(C(=O)n2ccc3ccccc32)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.51
RAB9A P51151 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
NOTUM Q6P988 1/20 0.46
TNF P01375 1/20 0.45
NOD2 Q9HC29 1/20 0.45
NOD1 Q9Y239 1/20 0.45
GRM4 Q14833 1/20 0.45
KMT2A Q03164 2/20 0.40
HTR6 P50406 2/20 0.39
GLA P06280 1/20 0.39
THRB P10828 1/20 0.39
JAK2 O60674 1/20 0.38
TYK2 P29597 1/20 0.38
SLC22A12 Q96S37 2/20 0.38
GAA P10253 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29494636 0.82 RAB9A (0.60) TSHRRAB9AL3MBTL1NOTUMGRM4
SCHEMBL8447109 0.82 RAB9A (0.60) TSHRRAB9AL3MBTL1NOTUMGRM4
SCHEMBL7079327 0.79 KMT2A (0.51) TSHRRAB9AL3MBTL1NOTUMGRM4
SCHEMBL28529485 0.76 RAB9A (0.60) TSHRRAB9AL3MBTL1NOTUMKMT2A
SCHEMBL18996999 0.75 GRM4 (0.43) TSHRGRM4KMT2ASLC22A12
SCHEMBL18983601 0.75 GRM4 (0.43) TSHRGRM4KMT2ASLC22A12
SCHEMBL7081253 0.74 MAPK14 (0.59) TSHRRAB9AL3MBTL1NOTUMGRM4
SCHEMBL7080354 0.74 JAK2 (0.44) TSHRTNFNOD2NOD1KMT2A
SCHEMBL9654115 0.72 L3MBTL1 (0.69) TSHRRAB9AL3MBTL1NOTUMKMT2A
SCHEMBL28835529 0.72 TSHR (0.51) TSHRRAB9AL3MBTL1NOTUMTNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed
WO-2002083622-A2 NOVEL AMINOPHENYL KETONE DERIVATIVES LEO PHARMA A/S (DK) 2002-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 TSHR 4784/4885RAB9A 3059/4885L3MBTL1 2248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.